GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
1.550
+0.080 (5.44%)
At close: May 12, 2025, 4:00 PM
1.540
-0.010 (-0.65%)
After-hours: May 12, 2025, 7:52 PM EDT
GRI Bio Market Cap
GRI Bio has a market cap or net worth of $814.31 thousand as of May 12, 2025. Its market cap has decreased by -41.76% in one year.
Market Cap
814.31K
Enterprise Value
-4.09M
1-Year Change
-41.76%
Ranking
Category
Stock Price
$1.55
Market Cap Chart
Since April 24, 2023, GRI Bio's market cap has decreased from $25.38M to $814.31K, a decrease of -96.79%. That is a compound annual growth rate of -81.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 772.28K | -89.56% |
| Dec 31, 2024 | 7.40M | 325.43% |
| Dec 29, 2023 | 1.74M | -93.15% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |